Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the disease, according to a preclinical study by investigators at Weill Cornell Medicine.

2 Jun 2022

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Aerobic exercise reprograms the immune system to reduce pancreatic tumor growth and amplify the effects of immunotherapy, a new study finds.

2 Jun 2022

New discovery could lead to highly effective ways to treat influenza

It happens every year, especially in winter. A virus saunters into your wide-open respiratory tract, worms its way into lung cells, and, next thing you know, you're lying in bed with a fever, aches, and chills - classic symptoms of influenza, or flu.

1 Jun 2022

Pneumonia frequency and severity found to be lower in patients with full COVID-19 vaccination

According to ARRS' American Journal of Roentgenology (AJR), evaluating chest CT findings offers an additional approach for demonstrating the efficacy of different COVID-19 vaccines in reducing the impact of a COVID-19 diagnosis.

1 Jun 2022

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

Survival has improved greatly in children with acute lymphocytic leukemia (ALL). But a certain form of ALL that occurs mostly in babies is still very lethal, with a survival rate below 50 percent: B-cell acute lymphoblastic leukemia with rearrangements of the mixed lineage leukemia gene, or MLL B-ALL.

1 Jun 2022

Study finds a link between aging and cancer metastases

Spreading cancer cells that escape a primary tumor site can seed in tissues distant from the tumor, but may take several years or decades to grow into full metastatic cancers.

1 Jun 2022

Black patients with early-onset colorectal cancer receive worse, less timely care than white counterparts

In a new large national study led by researchers at the American Cancer Society, Black patients diagnosed with early-onset colorectal cancer received worse and less timely care than their white counterparts.

31 May 2022

COVID-19 pandemic increased the number of cancer-related mortality in the U.S., study shows

According to a new study led by researchers at the American Cancer Society (ACS), the COVID-19 pandemic increased the number of cancer-related deaths by 3.2% in the United States from 2019- 2020.

31 May 2022

Parental cancer linked with greater chances of family-level food insecurity, financial worry for children

In a new large study led by researchers at the American Cancer Society (ACS), findings show parental cancer is associated with a greater likelihood of family-level food insecurity, financial worry about housing costs and other monthly bills, and transportation barriers to medical care for children in the United States.

31 May 2022

UCLA researchers identify a method to make tumors susceptible to immune attack

One powerful way cancer cells defend against tumor-killing immune cells is to load up their cell surface with a protein known as PD-L1. Now a team of UCLA Jonsson Comprehensive Cancer Center researchers led by Roger S. Lo, MD, PhD, has identified a method to degrade tumor cell-surface PD-L1, thereby making tumors susceptible to immune attack.

31 May 2022

Scientists develop new way to attack synovial sarcoma using an investigational drug

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma - a rare tumor of soft tissues, such as ligaments and muscles - using an investigational drug that triggers cell death.

31 May 2022

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

A new large national study led by researchers at the American Cancer Society shows the mortality risk from cardiovascular disease (CVD) differs considerably among cancer survivors by race/ethnicity and cancer types.

31 May 2022

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies, according to a study published in the Journal of Clinical Oncology.

31 May 2022

New Stad Center for Pediatric Pain, Palliative & Integrative Medicine launched with a $3 million gift

With a $3 million gift from Elisa and Marc Stad, UCSF Benioff Children's Hospitals have launched the Stad Center for Pediatric Pain, Palliative & Integrative Medicine – one of the most innovative and comprehensive programs of its kind in the nation.

31 May 2022

IOB's new scRNA-seq protocol provides a snapshot of the cell transcriptome at unprecedented resolution

Single-cell RNA-sequencing (scRNA-seq) shows which genes are turned on in a cell and what their level of transcription is. This allows in-depth assessment of the biology of individual cells, and detection of changes that may indicate disease.

31 May 2022

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.

30 May 2022

Medical cannabis use shown to improve cancer-related symptoms in new study

Researchers describe the effectiveness and safety of medical cannabis use for treating cancer-related symptoms.

30 May 2022

Combined treatment approach proves to be beneficial for prostate cancer patients

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy - a commonly used hormone injection - plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.

26 May 2022

Children from historically marginalized groups or poor backgrounds less likely to survive neuroblastoma

Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led by investigators from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

26 May 2022

Patient’s perspective on their physical well-being can help better predict cancer treatment outcomes

A breast cancer patient’s perspective on their physical well-being can provide a better indication of their response to cancer treatment than clinician-based tools, a new study has found, highlighting the importance of shared decision-making in the treatment process.

26 May 2022

Oncology News and Research

Further Reading

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

New discovery could lead to highly effective ways to treat influenza

Pneumonia frequency and severity found to be lower in patients with full COVID-19 vaccination

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

Study finds a link between aging and cancer metastases

Black patients with early-onset colorectal cancer receive worse, less timely care than white counterparts

COVID-19 pandemic increased the number of cancer-related mortality in the U.S., study shows

Parental cancer linked with greater chances of family-level food insecurity, financial worry for children

UCLA researchers identify a method to make tumors susceptible to immune attack

Scientists develop new way to attack synovial sarcoma using an investigational drug

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

New Stad Center for Pediatric Pain, Palliative & Integrative Medicine launched with a $3 million gift

IOB's new scRNA-seq protocol provides a snapshot of the cell transcriptome at unprecedented resolution

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Medical cannabis use shown to improve cancer-related symptoms in new study

Combined treatment approach proves to be beneficial for prostate cancer patients

Children from historically marginalized groups or poor backgrounds less likely to survive neuroblastoma

Patient’s perspective on their physical well-being can help better predict cancer treatment outcomes

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News